EXCLUSIVE: NBEO unveils board certification process

Article

Recently, the National Board of Examiners in Optometry (NBEO) launched a program to offer board certification to optometrists, with the first test taking place in March 2014. A new non-profit entity, NBEO-Board Certification, Inc., (NBEO-BC) was created to grant board certification. The company worked with the NBEO to develop the Continued Professional Development in Optometry (CPDO) exam.

Recently, the National Board of Examiners in Optometry (NBEO) launched a program to offer board certification to optometrists, with the first test taking place in March 2014.

A new non-profit entity, NBEO-Board Certification, Inc., (NBEO-BC) was created to grant board certification. The company worked with the NBEO to develop the Continued Professional Development in Optometry (CPDO) exam.

“There has been confusion for a number of years,” says Jack Terry, OD, PhD, president of NBEO-BC, and executive director of NBEO, speaking exclusively to Optometry Times. “We know that a large number of optometrists have felt that they are board certified purely because they had passed NBEO Parts I, II, and III and Treatment and Management of Ocular Disease (TMOD). The National Board has felt that board certification without a significant maintenance of certification program is an inappropriate alignment.”

As the National Boards currently stand, optometrists are not required to reassess their knowledge after passing Parts I-III and TMOD. Instituting the CPDO exam will give optometrists the opportunity to stay current with changes in optometric knowledge.

Says Terry: “The impetus behind this board certification is to acknowledge the currency of having passed the National Boards Parts I, II, III, and TMOD and that there is a certain shelf life of knowledge that has been assessed. Right now, there is no reassessment ever through NBEO. There is no maintenance of certification. There is no way to give individual optometrists insight via an intermittent diagnostic report on how well they’ve done in keeping up with the science of optometry. This new program will solve some of those awkward issues.”

Maintenance of certification will be required every 7 years for ODs certified under NBEO’s program. In addition to knowing passage or failure, optometrists taking the maintenance exam will know strengths and weaknesses of 9 assessment topics. Such information will allow ODs to tailor ongoing continuing education to bolster areas of weakness.

The CPDO exam carries a $500 fee and will be administered at more than 200 testing centers across the country. The first test is scheduled for March 3, 2014, and another date is planned for the third quarter of 2014. Moving forward, the number of exam dates per year will increase as demand grows.

NBEO and NBEO-BC announced the new board certification program via its Web sites. NBEO is in the process of sending letters and e-mails to its members with information.

 

Requirements for board certification

According to the NBEO-BC Web site, TPA-certified optometrists interested in NBEO board certification must fulfill one NBEO exam passage requirement and one experience-related requirement.

 

NBEO exam passage requirements:

• ODs graduating earlier than 1987: passed NBEO Parts I, II (or IIa or IIb), TMOD, and take CPDO within 3 years

• ODs graduating 1987-1993: passed NBEO Parts I, II, TMOD, and take CPDO within 4 years

• ODs graduating 1994-2014: passed NBEO Parts I, II, III, TMOD, and take CPDO within 6 years

• ODs graduating 2015 and beyond, passed NBEO Parts I, II, III, TMOD, Injections, and take CPDO within 7 years

 

Experience-related requirements:

• Complete 3 years of active practice

• Attain a score of 450 or above on all NBEO Parts I, II (IIa or IIb) and III, PLUS 2 years of active practice

• Complete a 1-year ACOE accredited residency

All NBEO board certified optometrists must agree to participate in the NBEO-BC maintenance of certification program. 

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.